康华生物：2025年归母净利润同比预降41.55%~52.09%

Group 1 - The core viewpoint of the article indicates that Kanghua Biological is forecasting a significant decline in its net profit for the fiscal year 2025, with an expected range of 191 million to 233 million yuan, representing a year-on-year decrease of 41.55% to 52.09% compared to the previous year's net profit of 399 million yuan [2] Group 2 - The company anticipates a challenging financial outlook for 2025, which may impact investor sentiment and market performance [2] - The projected decline in net profit highlights potential operational or market challenges that the company may be facing [2] - The announcement reflects broader trends in the industry that could affect similar companies and their financial forecasts [2]